Batf is a basic leucine zipper transcription factor belonging to the activator protein-1 superfamily. Batf expression is regulated following stimulation of both lymphoid and myeloid cells. When treated with leukemia inhibitory factor, mouse M1 myeloid leukemia cells commit to a macrophage differentiation program that is dependent on 
INTRODUCTION
The activator protein-1 (AP-1) transcription factor is comprised of dimerizing basic leucine zipper (bZIP) proteins of the widely expressed Jun, Fos, and Atf protein families and of the more tissue-restricted Maf and Batf families (1, 2) . Batf, the founding member of the Batf protein family (3) , is expressed at low levels in both myeloid and lymphoid cells and is induced by a variety of stimuli (4) (5) (6) (7) (8) (9) . Batf proteins preferentially form heterodimers with the Jun proteins and while Batf/Jun dimers bind equally well as Fos/Jun dimers to AP-1 consensus DNA, they possess a reduced ability to transactivate gene expression (3, 5, 10, 11) . Consistent with this role as an AP-1 inhibitor, overexpression of Batf effectively blocks the ability of AP-1-associated signaling pathways to stimulate cell growth (5, 6, 12, 13) . On the other hand, lymphocytes from Batf knock-out mice do not display the reciprocal phenotype of increased proliferation, but instead display defects in the differentiation of specific T helper cell subsets, in cytokine gene expression and in the responsiveness of B cells to antigen presentation (14, 15) . This apparent contradiction in behavior supports evidence that AP-1 functions in cellular processes as diverse as cellular transformation, differentiation and apoptosis and that the role of a cell-specific AP-1 component, such as Batf, will depend on the cellular context in which it is expressed (1).
In an effort to learn more about the impact of Batf on the growth and differentiation properties of individual blood cell types, we chose to study the mouse M1 myeloid leukemia cell line (16) . M1 cells proliferate as a transformed blast cell population until exposed to a member of the IL-6/LIF family of cytokines (17) (18) (19) , at which point the cells exit the cell cycle and initiate a program duplicating many aspects of monocyte to macrophage differentiation (20) . Binding of the appropriate cytokine to the gp130 receptor complex and subsequent activation of Jak-Stat3 signaling are critical to this developmental program (21, 22) . M1 cells have been exploited to identify myeloid differentiation (MyD) primary response genes as well as genes encoding key cell cycle regulators, transcription factors and structural proteins that are necessary to convert blast cells to terminally differentiated macrophages (20, 23) . Interestingly, the list of genes that fit the profile of MyD genes in this system includes c-Jun, JunB, JunD and
Batf, but not c-Fos (7, 24) . Thus, M1 cells provide an opportunity to examine the impact of Batf/Jun heterodimers on a well-defined program of myeloid lineage differentiation.
In this study, we investigated the mechanisms underlying the rapid induction of Batf 
MATERIALS AND METHODS

Cell culture
Mouse M1 myeloid leukemia cells (ATCC, TIB-192), A20 B lymphoma cells (ATCC, TIB-208) and primary mouse bone marrow cells were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum (Gibco/Invitrogen), penicillin (100 U/ml) and streptomycin (100 μg/ml). Primary mouse bone marrow cells were isolated from 8 week old C57BL/6 mice (Harlan Laboratories). Briefly, both femurs were dissected and marrow removed by forcing RPMI-1640 growth medium through the bone cavity with a 26-guage needle. Cells were pelleted by centrifugation at 1000 rpm for 5 min at 4 o C, resuspended in RPMI-1640 growth medium, counted and plated.
Recombinant mouse interleukin-6 (IL-6) (Gibco/Invitrogen) was used at a concentration of 50 ng/ml and human leukemia inhibitory factor (LIF1005, Chemicon International) was used at a concentration of 5 ng/ml. AG490 (Calbiochem) was stored at -20°C as a 17 mM stock solution in dimethyl sulfoxide (DMSO). To generate Batf-RNAi and NegRNAi cells, 1 X 10 7 M1 cells in 250 μl of PBS containing 50 μg of plasmid DNA were electroporated at 310 V, 950 μF and allowed to recover for 24 hr in RPMI-1640 growth medium prior to selection with 200 μg/ml G418 (Cellgro). Batf-RNAi clone 11 cells were isolated from the stable Batf-RNAi cell pool by limiting dilution. To generate the Batf RNAi + BATF and Batf RNAi + EGFP cells, Batf-RNAi cells were exposed overnight to virus supernatants from 293FT cells (gift from S. F. Konieczny) expressing the appropriate retroviral vector. Infected cells were transferred to RPMI-1640 growth medium for 24 hr prior to selection using both G418 and 1 μg /ml puromycin (Sigma). 
RNA and protein analysis
Total RNA was isolated from bone marrow cells or M1 cell lines treated with IL-6, LIF, AG490 or vehicle control (times and concentrations are indicated in Figure legends) using Trizol Reagent (Invitrogen). Real-time, quantitative reverse transcription PCR (RT-qPCR) was performed as described (15) using an Applied Biosystems 7300 thermocycler and the FastStart Universal SYBR Green PCR system (Roche) with the following primers for Batf (f 5' GAAGAATCGCATCGCTGC 3'; r 5' GTTCTGTTTCTCCAGGTCC 3'); c-myb (QT00123340, Qiagen) and ȕ-actin (QT00095242, Qiagen) as a control. Rapid amplification of 5' cDNA ends was performed using the 5' RACE System (Gibco/Invitrogen). For the analysis of protein expression, 50 μg of total cell extract or 100 μg of nuclear extract were prepared, resolved by SDS-PAGE and immunoblotted as described (28, 29) . Primary antibodies were used at a 1:1000 dilution and were purchased from Santa Cruz (anti-Stat3, H-190;
anti-Hsp-60, N-20; anti-Hsp-90ɲ/ɴ, H-114), Millipore (anti-phospho-Stat3, clone 9E12), Roche (anti-HA, clone 3F10) or ICN Pharmaceutical (anti-Actin, clone C4). The rabbit polyclonal anti-Batf antiserum was described previously (9) . The appropriate, secondary HRP-conjugated antibodies were purchased from Santa Cruz and used at a 1:5000 dilution. Antibody complexes were visualized using SuperSignal West Dura Extended Duration Substrate Kit (Pierce) and X-ray film (Kodak).
Plasmid DNAs
The -1000 B-Luc reporter gene was constructed by inserting an EcoRV/KpnI BamHI/EcoRI fragment, respectively, into the pBABE-puro vector (28) .
Luciferase assays
Reporter gene expression was monitored using the Dual Luciferase Assay system (Promega). 5 X 10 6 M1 cells per 60 mm dish were transfected using the SuperFect® protocol (Qiagen), 5 μg of the indicated luciferase reporter gene and 0.1 μg of Renilla luciferase gene as a normalization control. After 24 hr, LIF was added for 6 hr and cell extracts were assayed for luciferase activity as described previously (30) . 
Electrophoretic mobility shift assays (EMSA)
The procedures for the preparation of nuclear extracts, radio-labeling of probe DNA and performing EMSA have been described previously (13) . Oligonucleotide probes for mouse (M) and human (H) Stat A, B, and C are indicated in Figure 3A .
Competitor oligonucleotides were as follows: Stat3 (sc2571, Santa Cruz), mutStat3 (sc2572, Santa Cruz), mutC (5'-TCCAGCGTGAGGGACCAGAAACCA-3'), ABC (a 173 bp DNA fragment spanning all 3 Stat3 sites) and AB mutC (an ABC variant with mutC). These oligos were added in 100-fold molar excess directly to the binding reactions. protein (Y705F) or the Janus kinase (Jak) inhibitor, Socs1/Jab (7). This implies that Batf is a direct target of the Stat3 transcription factor. As a further demonstration that JakStat signaling is important for the induction of Batf mRNA in this system, we employed AG490, a potent and specific inhibitor of the Jak2 and Jak3 tyrosine kinases (32, 33) . Representative plots and images of each experimental group are presented in Figure   5D . The cumulative data from three independent experiments are tabulated in Figure   5E . While over 40% of control cells demonstrate substantial phagocytic activity, neither Collectively, the data presented in Figure 5 support the hypothesis that Batf plays a pivotal role in the LIF-induced growth arrest that is a prerequisite for the differentiation of M1 cells to functional macrophages in culture.
Expression of human BATF rescues the differentiation-defective phenotype of
Batf-RNAi cells. probe, protein binding was enhanced by LIF and was effectively competed using unlabeled A DNA (self), AP-1 DNA and, to a lesser degree, by the related CRE consensus DNA (Figure 7D, top panel, lanes 5-7) . Incubation with excess SP-1 DNA had no effect on A binding and the addition of anti-Batf antiserum, not control serum (anti-Mist1), to the reaction resulted in a partial supershift (Figure 7D, top panel, lanes   8-10) . For the B probe, overall protein binding was enhanced minimally by LIF. 
Batf-RNAi silences mouse
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DISCUSSION
M1 myeloid leukemia cells are a classic experimental model system that has generated a wealth of information on signaling pathways and target genes that reverse leukemogenicity, cause cell cycle arrest and promote the differentiation of myeloblasts to the monocyte/macrophage lineage (16, 20) 
